The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
Open accessAbstract
Purpose: To define human papillomavirus (HPV) –positive oropharyngeal cancers (OPC) suitable for treatment deintensification according to low risk of distant metastasis (DM). Patients and Methods: OPC treated with radiotherapy (RT) or chemoradiotherapy (CRT) from 2001 to 2009 were included. Outcomes were compared for HPV-positive versus HPV-negative patients. Univariate and multivariate analyses identified outcome predictors. Recursive partitioning analysis (RPA) stratified the DM risk. Results: HPV status was ascertained in 505 (56%) of 899 consecutive OPCs. Median follow-up was 3.9 years. HPV-positive patients (n = 382), compared with HPV-negative patients (n = 123), had higher local (94% v 80%, respectively, at 3 years; P < .01) and regional control (95% v 82%, respectively; P < .01) but similar distant control (DC; 90% v 86%, respectively; P = .53). Multivariate analysis identified that HPV negativity (hazard ratio [HR], 2.9; 95% CI, 2.0 to 5.0), N2b-N3 (HR, 2.9; 95% CI, 1.8 to 4.9), T4 (HR, 1.8; 95% CI, 1.2 to 2.9), and RT alone (HR, 1.8; 95% CI, 1.1 to 2.5) predicted a lower recurrence-free survival (RFS; all P < .01). Smoking pack-years > 10 reduced overall survival (HR, 1.72; 95% CI, 1.1 to 2.7; P = .03) but did not impact RFS (HR, 1.1; 95% CI, 0.7 to 1.9; P = .65). RPA segregated HPV-positive patients into low (T1-3N0-2c; DC, 93%) and high DM risk (N3 or T4; DC, 76%) groups and HPV-negative patients into different low (T1-2N0-2c; DC, 93%) and high DM risk (T3-4N3; DC, 72%) groups. The DC rates for HPV-positive, low-risk N0-2a or less than 10 pack-year N2b patients were similar for RT alone and CRT, but the rate was lower in the N2c subset managed by RT alone (73% v 92% for CRT; P = .02). Conclusion: HPV-positive T1-3N0-2c patients have a low DM risk, but N2c patients from this group have a reduced DC when treated with RT alone and seem less suited for deintensification strategies that omit chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Cox, J. D., Stetz, J., & Pajak, T. F. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00060-c · Cited by 4,792
Multiple imputation after 18+ years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476908 · Cited by 4,072
TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Gillison, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.709 · Cited by 3,101
Pignon, J.-P., Maître, A. L., Maillard, E., & Bourhis, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.04.014 · Cited by 3,069
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
Multiple primary malignant tumors. A survey of the literature and a statistical study
Warren, S. (1932) · American Journal of Cancer · Cited by 1,993
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
International Union Against Cancer (UICC)
Turner, B. (2012) · The Statesman’s Yearbook · doi:10.1007/978-1-349-59541-9_43 · Cited by 720
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
Browman, G. P., Wong, G., Hodson, I., Sathya, J., Russell, R., McAlpine, L., Skingley, P., & Levine, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280302 · Cited by 600
Gillison, M. L., Zhang, Q., Jordan, R., Xiao, W., Westra, W. H., Trotti, A., Spencer, S., Harris, J., Chung, C. H., & Ang, K. K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4099 · Cited by 487
Maxwell, J. H., Kumar, B., Feng, F. Y., Worden, F. P., Lee, J. S., Eisbruch, A., Wolf, G. T., Prince, M. E., Moyer, J. S., Teknos, T. N., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2350 · Cited by 306
Chen, A. M., Chen, L. M., Vaughan, A., Sreeraman, R., Farwell, D. G., Luu, Q., Lau, D. H., Stuart, K., Purdy, J. A., & Vijayakumar, S. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.050 · Cited by 210
Lassen, P., Eriksen, J. G., Krogdahl, A., Therkildsen, M. H., Ulhøi, B. P., Overgaard, M., Specht, L., Andersen, E., Johansen, J., Andersen, L. J., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.02.010 · Cited by 200
Analysing and interpreting competing risk data
Pintilie, M. (2007) · Statistics in Medicine · doi:10.1002/sim.2655 · Cited by 186
O’Sullivan, B., Huang, S. H., Perez-Ordonez, B., Massey, C., Siu, L. L., Weinreb, I., Hope, A., Kim, J., Bayley, A. J., Cummings, B., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.02.009 · Cited by 183
Self-citationKoutcher, L. D., Sherman, E. J., Fury, M. G., Wolden, S. L., Zhang, Z., Mo, Q., Stewart, L., Schupak, K. D., Gelblum, D. Y., Wong, R. J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.07.008 · Cited by 136
Point-of-care outcome assessment in the cancer clinic: Audit of data quality
Wong, K., Huang, S. H., O’Sullivan, B., Lockwood, G., Dale, D., Michaelson, T., Waldron, J. N., Bayley, A., Cummings, B., Dawson, L. A., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.03.015 · Cited by 131
Self-citationHoff, C. M., Grau, C., & Overgaard, J. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.01.011 · Cited by 128
Pytynia, K. B., Grant, J. R., Etzel, C. J., Roberts, D. B., Wei, Q., & Sturgis, E. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.133 · Cited by 91
Optimising the therapeutic ratio in head and neck cancer
Corry, J. F., Peters, L. J., & Rischin, D. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70384-5 · Cited by 63
Head and Neck Cancer Among Lifelong Never-Smokers and Ever-Smokers
Chen, A. M., Chen, L. M., Vaughan, A. T., Farwell, D. G., Luu, Q. C., Purdy, J. A., & Vijayakumar, S. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181dea40b · Cited by 29
Cited by
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
Marur, S., & Forastiere, A. A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.12.017 · Cited by 1,174
Mehanna, H., Robinson, M., Hartley, A., Kong, A., Foran, B., Fulton-Lieuw, T., Dalby, M., Mistry, P., Sen, M., O'Toole, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32752-1 · Cited by 1,041
Machiels, J.-P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., & Gregoire, V. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.011 · Cited by 916
The changing therapeutic landscape of head and neck cancer
Cramer, J. D., Burtness, B., Le, Q. T., & Ferris, R. L. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0227-z · Cited by 783
O'Sullivan, B., Huang, S. H., Su, J., Garden, A. S., Sturgis, E. M., Dahlstrom, K., Lee, N., Riaz, N., Pei, X., Koyfman, S. A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00560-4 · Cited by 750
Self-citation
Metadata
- Authors
- O'Sullivan, B., Huang, S. H., Siu, L. L., Waldron, J., Zhao, H., Perez-Ordonez, B., Weinreb, I., Kim, J., Ringash, J., Bayley, A., Dawson, L. A., Hope, A., Cho, J., Irish, J., Gilbert, R., Gullane, P., Hui, A., Liu, F.-F., Chen, E., & Xu, W.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-02-10
- Volume
- 31
- Issue
- 5
- Pages
- 543-550
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2124891284
- Cited by
- 592
- References
- 25
- FWCI
- 62.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.